About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Delayed Drug In New Zealand Markets

by Medindia Content Team on June 26, 2006 at 12:06 PM
Font : A-A+

Delayed Drug In New Zealand Markets

Diabetics in New Zealand are welcoming a Pharmac decision to fund long-acting insulin, that has been available abroad for years.

The government agency that purchases drugs announced yesterday that it would fund the insulin, glargine, from July 1. It is also known by its trade name, Lantus.

Advertisement

Wayne McNee, Pharmac chief executive, said the drug, which was priced at $5 million, reduces the risk of hypo glycaemia which could lead to muscle weakness, confusion and sweating, and in the worst cases, to coma.

Community liaison officer of Diabetes Society, Lynne Taylor, welcomed the decision, but said it had taken too long for Pharmac to come out with the drug, as the patient lobby has been demanding it for at least 18 months.

Complications of un-controlled diabetes include problems of the eye, kidney and heart.

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Goji Berries May Protect Against Age-Related Vision Loss
Tapping — A Proven Self-Applied Stress Intervention
Black Pepper as Preventive Measure Against Omicron
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity 
Recommended Reading
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)